Stocks · Health care · Pharmaceutical Preparations

Immuneering Corp

IMRX Clue Score35
United States Fiscal year ends December CIK 0001790340 Results filed 29 Oct 2026

What the insiders did Net buying

By person

15 insiders · 78 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Peter Feinberg
Director
$5.20M (16)
—
+$5.20M
407,648
$1.86M
—
Robert J Carpenter
Director
$4.88M (1)
—
+$4.88M
1,148,839
$5.24M
+89.4%
Cormorant Asset Management, LP entity
10% owner
$8.25M (1)
$3.91M (13)
+$4.34M
5,147,901
$23.48M
+22.4%
Benjamin J. Zeskind
President and CEO
$254.46K (8)
—
+$254.46K
2,860,179
$13.05M
+4.2%
Thomas J. Schall
Director
$232.49K (4)
—
+$232.49K
74,530
$339.98K
—
Ann E Berman
Director
$214.34K (3)
—
+$214.34K
67,465
$307.76K
—
Laurie Keating
Director
$140.00K (2)
—
+$140.00K
14,000
$63.86K
—
Brett Matthew Hall
Chief Scientific Officer
$128.78K (8)
—
+$128.78K
382,531
$1.74M
—
Biren Amin
CFO, Treasurer
$67.05K (2)
—
+$67.05K
7,898
$36.03K
—
Harold Eugene Brakewood
Chief Business Officer
$39.81K (3)
—
+$39.81K
11,050
$50.41K
—
Michael Bookman
Chief Legal Officer, Secretary
$32.88K (3)
—
+$32.88K
4,870
$22.22K
—
Leah R Neufeld
Chief People Officer
$29.50K (4)
—
+$29.50K
29,598
$135.02K
—
Diana Hausman
Director
$19.86K (2)
—
+$19.86K
5,500
$25.09K
—
Scott Barrett
Chief Medical Officer
$16.74K (2)
—
+$16.74K
7,563
$34.50K
—
Mallory Morales
SVP Finance, CAO
$5.93K (3)
—
+$5.93K
27,533
$125.60K
+1,031%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.